William Blair on Medline Inc (MDLN) Post Conference: 'Management reiterated the most recent FDA warning letter is isolated' Jun 4, 2026 04:11AM
Medline completes $2.68 billion secondary stock offering May 28, 2026 04:30PM
Medline Inc. announces closing of upsized secondary offering of Class A common stock May 28, 2026 04:30PM
Medline announces participation in upcoming investor conferences May 27, 2026 07:30AM
Medline prices upsized secondary offering at $37 per share May 21, 2026 10:45PM


May 21, 2026 10:45PM Medline Inc. announces pricing of upsized secondary offering of Class A common stock
Mar 10, 2026 02:00PM Medline completes $3.5 billion secondary stock offering
Mar 10, 2026 02:00PM Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
Mar 4, 2026 08:00PM Medline prices secondary offering at $41 per share
Mar 4, 2026 08:00PM Medline Inc. announces pricing of secondary offering of class A common stock
Jan 12, 2026 05:01AM William Blair Starts Medline Inc (MDLN) at Outperform
Dec 18, 2025 04:05PM Medline closes $7.2 billion IPO with full underwriter option exercise
Dec 18, 2025 04:05PM Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares